Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Unilever PLC
  6. Ratings
    ULVR   GB00B10RZP78

UNILEVER PLC

(ULVR)
  Report
Delayed Quote. Delayed London Stock Exchange - 04/16 11:35:45 am
4157.5 GBX   -0.19%
04:53aUNILEVER  : UK government global hygiene coalition reaches 1 billion people
PU
04/15GLASS LEWIS ESG CONTROVERSY ALERT : Ulvr
MT
04/14UNILEVER  : Building a new future for the factory floor
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The company is one of the best yield companies with high dividend expectations.
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at GBX 4249.
  • Technically, the stock approaches a strong medium-term resistance at GBX 4336.
  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The technical configuration over the long term remains negative on the weekly chart below the resistance level at 4249 GBX
Ratings chart
Sector Other Personal Products
1st jan.Capitalisation (M$)Investor Rating
UNILEVER PLC-5.19%150 913
THE PROCTER & GAMBLE COMPAN..-1.36%337 975
THE ESTéE LAUDER COMPANIES ..17.32%113 286
HINDUSTAN UNILEVER LIMITED2.64%77 453
COLGATE-PALMOLIVE COMPANY-5.91%68 395
RECKITT BENCKISER GROUP PLC1.82%65 656
BEIERSDORF AKTIENGESELLSCHA..-3.09%24 866
LG HOUSEHOLD & HEALTH CARE ..-3.70%21 775
DABUR INDIA LIMITED7.68%13 637
GODREJ CONSUMER PRODUCTS LI..-1.11%10 042
WINNER MEDICAL CO., LTD.-16.02%9 118
MARICO LIMITED5.32%7 344
KOBAYASHI PHARMACEUTICAL CO..-20.22%7 225
COLGATE-PALMOLIVE (INDIA) L..0.26%5 728
KIMBERLY-CLARK DE MéXICO, S..5.88%5 559
POLA ORBIS HOLDINGS INC.27.89%5 444
More Results
Financials
Sales 2021 51 161 M 61 306 M 61 306 M
Net income 2021 5 930 M 7 106 M 7 106 M
Net Debt 2021 20 745 M 24 859 M 24 859 M
P/E ratio 2021 21,9x
Yield 2021 3,54%
Capitalization 126 B 151 B 151 B
EV / Sales 2021 2,87x
EV / Sales 2022 2,77x
Nbr of Employees 148 949
Free-Float 98,1%
Surperformance Ratings©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes